A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel

Kim N. Chi, T. Kheoh, C. J. Ryan, A. Molina, J. Bellmunt, N. J. Vogelzang, D. E. Rathkopf, K. Fizazi, P. W. Kantoff, J. Li, A. A. Azad, B. J. Eigl, D. Y.C. Heng, A. M. Joshua, J. S. de Bono, H. I. Scher